US equities
|
MU
$931.24
▲+1.87%
NVDA
$217.23
▼-1.84%
SNDK
$1,394.83
▼-0.61%
AMD
$562.23
▼-1.50%
SPCX
$148.62
▼-2.33%
INTC
$95.37
▼-2.80%
AAPL
$342.00
▼-0.28%
MSFT
$539.44
▲+1.08%
MU
$931.24
▲+1.87%
NVDA
$217.23
▼-1.84%
SNDK
$1,394.83
▼-0.61%
AMD
$562.23
▼-1.50%
SPCX
$148.62
▼-2.33%
INTC
$95.37
▼-2.80%
AAPL
$342.00
▼-0.28%
MSFT
$539.44
▲+1.08%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Ventripoint Diagnstcs Ltd
(TSV:
VPT
)
0.0800
-0.0050 (-5.88%)
Delayed Quote
Updated: 3:57 PM EDT, Oct 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ventripoint Diagnstcs Ltd
UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform
August 20, 2026
From
UniDoc Health Corp.
Via
ACCESS Newswire
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
August 12, 2026
Commercial initiative aims to make VMS+ easier for hospitals to evaluate and adopt
From
Ventripoint Diagnostics Ltd
Via
GlobeNewswire
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
May 13, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
April 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
April 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
Upcoming Meeting Dates - March 23, 2026
March 23, 2026
Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - The following is a list of Upcoming Meeting Dates announced this week...
Via
Newsfile
THE SIGNAL ARCHITECTURE: 5 Stocks Calibrating the 2026 Infrastructure Cycle
February 24, 2026
Issued on behalf of Quantum Secure Encryption Corp.
From
USA News Group
Via
GlobeNewswire
THE SOVEREIGNTY DOCTRINE: 5 Assets Locking Down the 2026 Survival Cycle
February 05, 2026
Issued on behalf of Quantum Secure Encryption Corp.
From
USA News Group
Via
GlobeNewswire
THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle
January 16, 2026
Issued on behalf of Ventripoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
THE FOUNDATION TRADE: 5 Assets Anchoring the Next Industrial Cycle
December 17, 2025
Issued on behalf of GoldHaven Resources Corp.
From
USA News Group
Via
GlobeNewswire
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
December 15, 2025
Issued on behalf of Ventripoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
Healthcare AI Exits Pilot Phase, Enters Production Deployment
December 12, 2025
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
From Hype to P&L: Hospitals Now Buying AI That Pays
December 08, 2025
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.
From
USA News Group
Via
GlobeNewswire
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
December 06, 2025
Issued on behalf of Oncolytics Biotech Inc.
From
USA News Group
Via
GlobeNewswire
UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
December 03, 2025
Issued on behalf of Oncolytics Biotech Inc.
From
USA News Group
Via
GlobeNewswire
The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
December 03, 2025
Issued on behalf of Oncolytics Biotech Inc.
From
USA News Group
Via
GlobeNewswire
Ventripoint's Next Generation, AI-powered Heart-Scanning Technology Submitted for EU Medical Device Regulation Certification
October 11, 2024
Toronto, Ontario - TheNewswire - (October 11, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce that it has submitted its next...
Via
TheNewswire.com
Topics
Artificial Intelligence
